Back to Search Start Over

Roche's Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness

Source :
M2 Presswire. December 13, 2024
Publication Year :
2024

Abstract

M2 PRESSWIRE-December 13, 2024-: Roche's Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness (C)1994-2024 M2 COMMUNICATIONS RDATE:13122024 * Vabysmo PFS is the [...]

Subjects

Subjects :
United States. Food and Drug Administration
Roche Holding AG
Blindness
Hypodermic syringes
Viral antibodies
Macular degeneration
Syringes
Antibodies
Hypodermic needles
Business
Business, international
European Union
Vabysmo (Medication)

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Presswire
Publication Type :
News
Accession number :
edsgcl.819730375

Tools

Authors Abstract Subjects Details